News tagged with patent
In a surprise move, federal health regulators have denied a request by Endo Health Solutions to block generic versions of its painkiller Opana ER, which the company argued can be more easily abused than its branded product.
Medications May 10, 2013 | not rated yet | 0
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics Apr 11, 2013 | 4.3 / 5 (6) | 16 |
The Supreme Court seemed worried Monday about the idea of companies patenting human genes in a case that could profoundly reshape the multibillion-dollar biomedical industry and U.S. research in the fight ...
Genetics Apr 15, 2013 | 5 / 5 (2) | 1
Researchers at Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have found that macrophages – white blood cells that play a key role in the immune response – also ...
Medical research Mar 17, 2013 | 4.7 / 5 (3) | 1 |
You don't 'own' your own genes: Researchers raise alarm about loss of individual 'genomic liberty' due to gene patents
Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially ...
Genetics Mar 26, 2013 | 4.8 / 5 (20) | 17 |
(Medical Xpress) -- Yale researcher Jose Cordova and Erich Astudillo from the University of Chile (and Founder of Top Tech Innovations SpA) have after working together, discovered a new molecule that kills the bacteria Streptococcus Mu ...
Dentistry Jul 10, 2012 | 4.5 / 5 (10) | 13 |
Just like the old Crystal Gayle song, a new laser technology could soon allow you to turn those boring brown eyes of your to a rich and beautiful blue. But you better make sure that blue eyes are what you really want because ...
Other Nov 04, 2011 | 4 / 5 (11) | 21 |
The most common cause of lower respiratory tract infections in infants and young children, respiratory syncytial virus (RSV), can be transferred during pregnancy to an unborn baby, according to Cleveland Clinic Children's ...
Diseases, Conditions, Syndromes Apr 18, 2013 | not rated yet | 0
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
Medications May 01, 2013 | not rated yet | 0
The Supreme Court grapples Monday with the question of whether human genes can be patented, and the ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian ...
Genetics Apr 15, 2013 | 5 / 5 (1) | 1
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications Apr 16, 2013 | not rated yet | 1
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Genetics Apr 13, 2013 | 5 / 5 (2) | 0
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications Mar 05, 2013 | 5 / 5 (4) | 3
Loyola University Chicago Stritch School of Medicine researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune ...
Medical research Feb 27, 2013 | 5 / 5 (1) | 0 |
Indian generics giant Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over the Mumbai firm's version of a lung-cancer drug.
Medications Sep 08, 2012 | 5 / 5 (4) | 2
A patent is a set of exclusive rights granted by a state to an inventor or his assignee for a limited period of time in exchange for a disclosure of an invention.
The procedure for granting patents, the requirements placed on the patentee and the extent of the exclusive rights vary widely between countries according to national laws and international agreements. Typically, however, a patent application must include one or more claims defining the invention which must be new, inventive, and useful or industrially applicable. In many countries, certain subject areas are excluded from patents, such as business methods and mental acts. The exclusive right granted to a patentee in most countries is the right to prevent others from making, using, selling, or distributing the patented invention without permission.
Under the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights, patents should be available in WTO member states for any inventions, in all fields of technology, and the term of protection available should be minimum twenty years. Different types of patents may have varying patent terms (i.e., durations).
For more information about Patent, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.